Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study

PURPOSE: Cancer-related cognitive impairment (CRCI) is a recognised adverse consequence of cancer and its treatment. This study assessed the feasibility of collecting longitudinal data on cognition in patients with newly diagnosed, aggressive lymphoma undergoing standard therapy with curative intent...

Descripción completa

Detalles Bibliográficos
Autores principales: Gates, Priscilla, Krishnasamy, Meinir, Wilson, Carlene, Hawkes, Eliza A., Doré, Vincent, Perchyonok, Yuliya, Rowe, Christopher C., Walker, Adam K., Vardy, Janette L., de Ruiter, Michiel B., Cushion, Tania, Dhillon, Haryana M., Gough, Karla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385796/
https://www.ncbi.nlm.nih.gov/pubmed/35699780
http://dx.doi.org/10.1007/s00520-022-07153-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385796/
https://www.ncbi.nlm.nih.gov/pubmed/35699780
http://dx.doi.org/10.1007/s00520-022-07153-9

Ejemplares similares